NovoCure Limited

NVCR
$15.33 (- $0.98 - 6.01%)
Last updated: 2026-07-29 18:34 UTC
NVCR Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryMedical Devices
ISINJE00BYSS4X48
Market Price15.33
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-1.63
Market Cap$1.5B
Book Value3.05
Price to Book4.409
Beta0.82
52w High32.05
52w Low10.7
Next Earnings DateN/A

NovoCure Limited trades under ticker NVCR on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN JE00BYSS4X48. Also searched as NovoCure.

Related researchNVCR stock priceNVCR share priceNovoCure stockNovoCure share price
About the Company
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Price History